Source Paper
Source Paper
Hiroyuki Nakayama, Xiongwen Chen, Christopher P. Baines, Raisa Klevitsky, Xiaoying Zhang et al.
Journal of Clinical Investigation • 2007
Loss of cardiac myocytes in heart failure is thought to occur largely through an apoptotic process. Here we show that heart failure can also be precipitated through myocyte necrosis associated with Ca2+ overload. Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis that led to pump dysfunction and premature death, effects that were dramatically enhanced by acute stimulation of beta-adrenergic receptors. Enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or beta-adrenergic receptor antagonists, demonstrating a proximal relationship among beta-adrenergic receptor function, Ca2+ handling, and heart failure progression through necrotic cell loss. Mechanistically, loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx-induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death. In contrast, overexpression of the antiapoptotic factor Bcl-2 was ineffective in mitigating heart failure and death associated with excess Ca2+ influx and acute beta-adrenergic receptor stimulation. This paradigm of mitochondrial- and necrosis-dependent heart failure was also observed in other mouse models of disease, which supports the concept that heart failure is a pleiotropic disorder that involves not only apoptosis, but also necrotic loss of myocytes in association with dysregulated Ca2+ handling and beta-adrenergic receptor signaling.
Objective: Assessment of progressive myocyte necrosis, pump dysfunction, and survival in inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel activity, and evaluation of mechanisms underlying Ca2+-dependent cardiomyocyte necrosis in heart failure
This is a Transgenic Mouse Cardiac Phenotyping protocol using mouse as the model organism. The procedure involves 10 procedural steps. Extracted from a 2007 paper published in Journal of Clinical Investigation.
Model and subjects
mouse • inducible transgenic • unknown • not specified • not specified
Study window
Estimated timing pending
Core workflow
Transgenic Mouse Generation and Induction • Assessment of Myocyte Necrosis • Evaluation of Pump Dysfunction
Primary readouts
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
Use the page like this
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel activity were generated and maintained
Note: Mice were inducible transgenic models designed to express enhanced LTCC activity
“Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis”
Progressive myocyte necrosis was assessed in transgenic mice with enhanced LTCC activity
Note: Necrosis was evaluated as a primary outcome measure
“Inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity showed progressive myocyte necrosis that led to pump dysfunction”
Cardiac pump dysfunction was assessed as a consequence of myocyte necrosis
Note: Pump dysfunction was measured as a secondary outcome
“progressive myocyte necrosis that led to pump dysfunction and premature death”
Acute stimulation of β-adrenergic receptors was applied to enhance the phenotype
Note: Effects were dramatically enhanced by acute stimulation of β-adrenergic receptors
“effects that were dramatically enhanced by acute stimulation of β-adrenergic receptors”
L-type Ca2+ channel blockers were administered to test prevention of necrosis and cardiomyopathy
Note: LTCC blockers prevented enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy
“Enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers”
β-adrenergic receptor antagonists were administered to test prevention of necrosis and cardiomyopathy
Note: β-adrenergic antagonists prevented enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy
“Enhanced Ca2+ influx-induced cellular necrosis and cardiomyopathy was prevented with either LTCC blockers or β-adrenergic receptor antagonists”
Transgenic mice with loss of cyclophilin D were evaluated to determine its role in necrosis regulation
Note: Cyclophilin D is a regulator of the mitochondrial permeability transition pore that underpins necrosis
“loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx-induced necrosis”
Transgenic mice with Bcl-2 overexpression were evaluated to test antiapoptotic factor effectiveness
Note: Bcl-2 overexpression was ineffective in mitigating heart failure and death associated with excess Ca2+ influx
“overexpression of the antiapoptotic factor Bcl-2 was ineffective in mitigating heart failure and death associated with excess Ca2+ influx”
Isoproterenol was used to induce acute β-adrenergic receptor stimulation and assess survival outcomes
Note: Isoproterenol-induced premature death was prevented by loss of cyclophilin D
“loss of cyclophilin D, a regulator of the mitochondrial permeability transition pore that underpins necrosis, blocked Ca2+ influx-induced necrosis of myocytes, heart failure, and isoproterenol-induced premature death”
The paradigm of mitochondrial- and necrosis-dependent heart failure was evaluated in other mouse models of disease
Note: Results were validated across multiple disease models
“This paradigm of mitochondrial- and necrosis-dependent heart failure was also observed in other mouse models of disease”
This section explains what the experiment is doing, which readouts matter, what the data artifacts usually look like, and how the analysis should flow from raw capture to reported result.
Assessment of progressive myocyte necrosis, pump dysfunction, and survival in inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel activity, and evaluation of mechanisms underlying Ca2+-dependent cardiomyocyte necrosis in heart failure
Objective
Assessment of progressive myocyte necrosis, pump dysfunction, and survival in inducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel activity, and evaluation of mechanisms underlying Ca2+-dependent cardiomyocyte necrosis in heart failure
Subjects
From papermouse • inducible transgenic • unknown • not specified • not specified
Cohort notes
From paperInducible transgenic mice with enhanced sarcolemmal L-type Ca2+ channel (LTCC) activity; also included transgenic mice with loss of cyclophilin D and Bcl-2 overexpression variants
Transgenic Mouse Generation and Induction (not specified)
Assessment of Myocyte Necrosis (not specified)
Evaluation of Pump Dysfunction (not specified)
Acute Beta-Adrenergic Receptor Stimulation (not specified)
Progressive myocyte necrosis
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Cardiac pump dysfunction
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Survival/premature death
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Ca2+ influx-induced cellular necrosis
From papernot specified in provided text
Artifact type
Endpoint measurements summarized by group or timepoint
Comparison focus
Compare endpoint magnitude between groups, timepoints, or both
Progressive myocyte necrosis
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Cardiac pump dysfunction
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Survival/premature death
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Ca2+ influx-induced cellular necrosis
From paperRaw artifact
Per-sample or per-animal endpoint measurements collected during the experiment
Processed artifact
Structured table with cleaned measurements ready for comparison
Final reported form
Summary statistics and between-group or across-timepoint comparisons
Acquisition
Collect raw experimental outputs with enough metadata to preserve sample identity, condition, and timing.
Preprocessing / cleaning
not specified in provided text
Scoring or quantification
Quantify the primary readouts for this experiment: Progressive myocyte necrosis; Cardiac pump dysfunction; Survival/premature death; Ca2+ influx-induced cellular necrosis.
Statistical comparison
Statistical method not yet structured for this page.
Reporting output
Report representative outputs alongside summary comparisons for Progressive myocyte necrosis, Cardiac pump dysfunction, Survival/premature death, Ca2+ influx-induced cellular necrosis.
Source links and direct wording from the methods section for validation and deeper review.
Citation
Hiroyuki Nakayama et al. (2007). Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. Journal of Clinical Investigation
“”
“”
“”
“”
Direct vendor pages are linked from the protocol above. This section stays focused on the full comparison view and the prep checklist.
Use this section as the page quality checkpoint. It keeps section navigation, evidence access, readiness, and verification meaning in one place.
Current status surfaces were computed from experiment data updated Feb 28, 2026.
Source access
Jump back into the original paper or the methods evidence section when you need exact wording, exclusions, or method-specific caveats.
This protocol has structured steps plus evidence quotes, and is ready for canonical sync.
Steps
10
Evidence Quotes
10
Protocol Items
0
Linked Products
0
Canonical Sync
Pending
What this means
The completeness score reflects how much structured protocol data is present: steps, methods evidence, listed materials, linked products, and paper provenance.
Computed from the current experiment record updated Feb 28, 2026.
Canonical Sync shows whether a ConductGraph-backed protocol is available for this experiment route right now. It is a sync-status signal, not a claim that every downstream vendor link or step detail is perfect.
Steps
10
Evidence
10
Specific Products
0/0
Canonical Sync
Pending
What this score means
The verification score reflects evidence coverage, subject detail, paper provenance, step depth, and whether linked products resolve to specific item pages instead of generic searches.
Computed from the current experiment record updated Feb 28, 2026.
A page can have structured steps and still need review when evidence is thin, product links are generic, or canonical protocol coverage is still pending.
What still needs work